Relationship between baseline plasma p‐tau181 and longitudinal changes in cognition and structural brain measures in a cohort of cognitively unimpaired older adults
Authors:
Open Access
- 1 October 2023
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 15 (4)
Abstract
INTRODUCTION: Preclinical Alzheimer's disease (AD) affects a significant proportion of cognitively unimpaired (CU) older adults. Currently, blood‐based biomarkers detect very early changes in the AD continuum with great accuracy.METHODS: We measured baseline plasma phosphorylated tau (p‐tau)181 using electrochemiluminescence (ECL)‐based assay (MesoScale Discovery) in 533 CU older adults. Follow‐up lasted up to 18 months. Cognitive performance assessment included memory and cognitive control. Structural brain measures included cortical thickness, which includes the AD magnetic resonance imaging (AD MRI) signature, and hippocampal volume.RESULTS: In this cohort of CU older adults, baseline plasma p‐tau181 levels were not associated with short‐term changes in cognition and structural brain measures. Also, baseline plasma p‐tau levels did not influence the effects of behavioral interventions (exercise or mindfulness) on cognitive and structural brain changes.DISCUSSION: The short follow‐up and healthy status of this CU cohort might have limited the sensitivity of plasma p‐tau181 in detecting changes associated with AD pathology.Keywords
Funding Information
- National Institutes of Health (R01AG049689, R01AG072694, R01MH115953)
This publication has 48 references indexed in Scilit:
- Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomographyAlzheimer's & Dementia, 2018
- Cortical microstructural changes along the Alzheimer's disease continuumAlzheimer's & Dementia, 2017
- Defining imaging biomarker cut points for brain aging and Alzheimer's diseaseAlzheimer's & Dementia, 2016
- Longitudinal brain structural changes in preclinical Alzheimer's diseaseAlzheimer's & Dementia, 2016
- Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer DiseaseJAMA Neurology, 2015
- Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseAnnals of Neurology, 2014
- Within-subject template estimation for unbiased longitudinal image analysisNeuroImage, 2012
- Design Considerations for Characterizing Psychiatric Trajectories Across the Lifespan: Application to Effects of APOE-ε4 on Cerebral Cortical Thickness in Alzheimer's DiseaseAmerican Journal of Psychiatry, 2011
- Larger temporal volume in elderly with high versus low beta-amyloid depositionBrain, 2010
- Factors associated with resistance to dementia despite high Alzheimer disease pathologyNeurology, 2009